CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 4,200 enrolled
Drug / intervention
Chlorfenapyr LLIN +3 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03554616
NCT03554616N/ACompleted

Efficacy of Three Different Bi-treated Long Lasting Insecticidal Nets and Deployment Strategy for Control of Malaria Transmitted by Pyrethroid Resistant Vectors: A Randomised Controlled Trial

London School of Hygiene and Tropical Medicine·interventional·Posted Jun 13, 2018·Updated Nov 26, 2024

In Brief

A clinical study evaluating Chlorfenapyr LLIN, pyriproxyfen LLIN, and 2 other interventions for Malaria and Anaemia. Completed, enrolled 4,200 participants across 1 site.

Detailed Summary

The massive scale-up of Long Lasting Insecticidal Nets (LLIN) has led to a major reduction in malaria burden (up to 50%) in many sub-Saharan African countries. This progress is threatened by the wide scale selection of insecticide resistant malaria vectors. New types of LLIN combining a mixture of two insecticides or an insecticide and a synergist have been developed to control resistant mosquitoes. The efficacy of three bi-treated LLIN are compared to a standard LLIN in a four-arm, single blinded, cluster-randomized trial in Misungwi district, Tanzania. The arms are; 1/ Royal Guard, a net combining pyriproxyfen (PPF), which is known to disrupt female reproduction and fertility of eggs, and the pyrethroid alpha-cypermethrin, 2/Interceptor G2, LLIN incorporating a mixture of two adulticides with different modes of action; chlorfenapyr and a pyrethroid (alpha-cypermethrin), and 3/ Olyset Plus an LLIN which incorporates a synergist, piperonyl butoxide (PBO), to enhance the potency of pyrethroid insecticides, and 4/ The control arm: Interceptor treated a standard LLIN treated with alpha-cypermethrin. The primary outcome of the trial will be cross-sectional community prevalence of malaria infection (by RDT) in children aged 6 months to 14 years at 12 and 24 months post-intervention.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsMalaria, Anaemia
CountriesTanzania

Timeline

N/ACompletedFinished
20192020202120222023202420252026
First PostedJun 13, 2018
Enrollment StartFeb 1, 2019
Primary CompletionFeb 28, 2022
Study CompletionFeb 1, 2023
TodayJul 2, 2026
Enrollment to primary: 3.1 yearsPosted 8.1 years ago

Interventions

Chlorfenapyr LLINother

Dual active ingredient Long Lasting Insecticidal Net

pyriproxyfen LLINother

Dual active ingredient Long Lasting Insecticidal Net

Piperonyl butoxide LLINother

Combination insecticide and synergist Long Lasting Insecticidal Net

Standard LLINother

Standard Long Lasting Insecticidal Net with one insecticide